Literature DB >> 20838457

Correspondence (letter to the editor): low-dose radiotherapy.

Ulrich Schäfer, Oliver Micke, Michael Heinrich Seegenschmiedt, Ralph Mücke.   

Abstract

Mesh：

Year:  2010        PMID： 20838457      PMCID： PMC2936793          DOI： 10.3238/arztebl.2010.0603b

Source DB:  PubMed          Journal:  Dtsch Arztebl Int        ISSN： 1866-0452            Impact factor:   5.594


× No keyword cloud information.
  4 in total

1.  [Radiotherapy of osteoarthritis. Indication, technique and clinical results].

Authors:  R Ruppert; M H Seegenschmiedt; R Sauer
Journal:  Orthopade       Date:  2004-01       Impact factor: 1.087

Review 2.  The epidemiology, etiology, diagnosis, and treatment of osteoarthritis of the knee.

Authors:  Joern W-P Michael; Klaus U Schlüter-Brust; Peer Eysel
Journal:  Dtsch Arztebl Int       Date:  2010-03-05       Impact factor: 5.594

3.  [Radiotherapy in painful gonarthrosis. Results of a national patterns-of-care study].

Authors:  Ralph Mücke; M Heinrich Seegenschmiedt; Reinhard Heyd; Ulrich Schäfer; Franz-Josef Prott; Michael Glatzel; Oliver Micke
Journal:  Strahlenther Onkol       Date:  2009-12-28       Impact factor: 3.621

4.  Radiation therapy for nonmalignant diseases in Germany. Current concepts and future perspectives.

Authors:  M Heinrich Seegenschmiedt; Oliver Micke; Norman Willich
Journal:  Strahlenther Onkol       Date:  2004-11       Impact factor: 3.621
  4 in total
  5 in total

1.  The Erlangen Dose Optimization Trial for radiotherapy of benign painful shoulder syndrome. Long-term results.

Authors:  O J Ott; S Hertel; U S Gaipl; B Frey; M Schmidt; R Fietkau
Journal:  Strahlenther Onkol       Date:  2014-02-07       Impact factor: 3.621

2.  Re-irradiation for osteoarthritis-retrospective analysis of 217 joints.

Authors:  Matthias G Hautmann; Philipp Rechner; Matthias Hipp; Ulrich Neumaier; Felix Steger; Fabian Pohl; Markus Weber; Oliver Kölbl; Christoph Süß
Journal:  Strahlenther Onkol       Date:  2019-07-25       Impact factor: 3.621

3.  Radiotherapy for calcaneodynia. Results of a single center prospective randomized dose optimization trial.

Authors:  O J Ott; C Jeremias; U S Gaipl; B Frey; M Schmidt; R Fietkau
Journal:  Strahlenther Onkol       Date:  2013-02-28       Impact factor: 3.621

4.  Benign painful shoulder syndrome: initial results of a single-center prospective randomized radiotherapy dose-optimization trial.

Authors:  O J Ott; S Hertel; U S Gaipl; B Frey; M Schmidt; R Fietkau
Journal:  Strahlenther Onkol       Date:  2012-11-07       Impact factor: 3.621

5.  Radiotherapy for benign calcaneodynia: long-term results of the Erlangen Dose Optimization (EDO) trial.

Authors:  Oliver J Ott; Carolin Jeremias; Udo S Gaipl; Benjamin Frey; Manfred Schmidt; Rainer Fietkau
Journal:  Strahlenther Onkol       Date:  2014-03-26       Impact factor: 3.621
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.